α-Synuclein as a Diagnostic Marker and Therapeutic Target for Parkinson Disease

被引：0
|
作者：
Luan Ming-Yue [1 ]
Wang Zhao-Xia [1 ,2 ]
Deng Jian-Wen [1 ,2 ]
机构：
[1] Peking Univ First Hosp, Dept Neurol, Beijing 100034, Peoples R China
[2] Beijing Key Lab Neurovasc Dis Discovery, Beijing 100034, Peoples R China
来源：
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS | 2022年 / 49卷 / 01期
基金：
中国国家自然科学基金;
关键词：
Parkinson disease; alpha-synuclein; biomarkers; therapy; DETECT LEWY PATHOLOGY; RED-BLOOD-CELLS; CEREBROSPINAL-FLUID; POTENTIAL BIOMARKER; PRESYNAPTIC PROTEIN; ALZHEIMERS-DISEASE; MUCOSA; PLASMA; SKIN; CSF;
D O I：
10.16476/j.pibb.2021.0346
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Parkinson disease (PD) is an insidious and progressive neurodegenerative disease. It is the second most common neurodegenerative disease affecting 1%-3% of the population over the age of 65. While the etiology of PD is complex, alpha-synuclein (alpha-syn) misfolding and aggregation is identified as the hallmark of PD. Due to lack of the reliable biomarkers, early diagnosis of this disease is difficult. In this review, we discuss recent research progresses in the development of PD biomarkers based on the detection of alpha-synuclein from different samples, including body fluids (cerebrospinal fluid, blood, saliva) and peripheral tissues (skin, olfactory mucosa, salivary gland, gut mucosa). Furthermore, we summarize the recent advances on the therapeutic approaches targeting alpha-synuclein in treating PD.
引用
收藏
页码：86 / 99
页数：14
相关论文
共 138 条
  • [11] Red blood cells are the major source of alpha-synuclein in blood
    Barbour, Robin
    Kling, Kristin
    Anderson, John P.
    Banducci, Kelly
    Cole, Tracy
    Diep, Linnea
    Fox, Michael
    Goldstein, Jason M.
    Soriano, Ferdie
    Seubert, Peter
    Chilcote, Tarnie J.
    [J]. NEURODEGENERATIVE DISEASES, 2008, 5 (02) : 55 - 59
  • [12] Submandibular Gland Biopsy for the Diagnosis of Parkinson Disease
    Beach, Thomas G.
    Adler, Charles H.
    Dugger, Brittany N.
    Serrano, Geidy
    Hidalgo, Jose
    Henry-Watson, Jonette
    Shill, Holly A.
    Sue, Lucia I.
    Sabbagh, Marwan N.
    Akiyama, Haruhiko
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2013, 72 (02) : 130 - 136
  • [13] Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7
  • [14] Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease
    Besong-Agbo, Daniela
    Wolf, Elias
    Jessen, Frank
    Oechsner, Matthias
    Hametner, Eva
    Poewe, Werner
    Reindl, Markus
    Oertel, Wolfgang H.
    Noelker, Carmen
    Bacher, Michael
    Dodel, Richard
    [J]. NEUROLOGY, 2013, 80 (02) : 169 - 175
  • [15] Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease
    Biosa, Alice
    Sandrelli, Federica
    Beltramini, Mariano
    Greggio, Elisa
    Bubacco, Luigi
    Bisaglia, Marco
    [J]. NEUROBIOLOGY OF DISEASE, 2017, 108 : 65 - 72
  • [16] Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
    Braak, H
    de Vos, RAI
    Bohl, J
    Del Tredici, K
    [J]. NEUROSCIENCE LETTERS, 2006, 396 (01) : 67 - 72
  • [17] Brys M, 2018, NEUROLOGY, V90
  • [18] Cell Biology and Pathophysiology of α-Synuclein
    Burre, Jacqueline
    Sharma, Manu
    Sudhof, Thomas C.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (03):
  • [19] Alpha-synuclein in salivary gland as biomarker for Parkinson's disease
    Campo, Flaminia
    Carletti, Raffaella
    Fusconi, Massimo
    PeRicano, Clelia
    Pontieri, Francesco E.
    Di Gioia, Cira R.
    de Vincentiis, Marco
    [J]. REVIEWS IN THE NEUROSCIENCES, 2019, 30 (05) : 455 - 462
  • [20] α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease
    Cao, Zhentang
    Wu, Yufeng
    Liu, Genliang
    Jiang, Ying
    Wang, Xuemei
    Wang, Zhan
    Feng, Tao
    [J]. NEUROSCIENCE LETTERS, 2019, 696 : 114 - 120
12345678910